Thursday, May 19, 2022
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina



Uzbekistan and China will produce anti-SARS-COV-2 coronavirus vaccine

Uzbekistan and China will produce anti-SARS-COV-2 coronavirus vaccine

Tashkent, Aug 12 (Prensa Latina) Chinese biopharmaceutical company Anhui Zhifei Longcom and Uzbek Jurabek Laboratories announced today the signing of an agreement for the purchase and production in this country of Chinese vaccines against Covid-19.
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

The Uzbek company has prepared a separate line for the production of the Anhui Zhifei Longkom Biopharmaceutical vaccine, which has already been audited by Chinese experts, TASS news agency reported.

It is expected that in the near future a series will be developed for the validation of the vaccine, after which its production will be authorized.

The drug to be developed in Uzbekistan will be obtained by producing the recombining protein NCP-RBD from SARS-CoV-2 coronavirus.


name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.